신약 연구 및 개발 바이오 기업, 회사 소개, 투자 정보 등 제공.
Location: South Korea, Gyeonggi, Seongnam-si
Employees: 11-50
Founded date: 2015
Investors 5
| Date | Name | Website |
| - | SV Investm... | svinvest.c... |
| - | Uno Invest... | unoi.co.kr |
| - | UTC Invest... | utc.co.kr |
| - | Company K ... | kpartners.... |
| - | KTB Networ... | ktbnetwork... |
Mentions in press and media 19
| Date | Title | Description | Source |
| 29.03.2024 | Bridge Biotherapeutics Launches a Research Collaboration wit... | SEONGNAM, South Korea and ATLANTA, March 29, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330),... | en.prnasia... |
| 27.03.2024 | Bridge Biotherapeutics Announces a Research Collaboration wi... | SEONGNAM, South Korea and AURORA, Colo., March 27, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ28... | en.prnasia... |
| 31.10.2023 | Bridge Biotherapeutics Announces Initiation of Phase 1/2 Cli... | SEONGNAM, South Korea and NEWTON, Mass., Oct. 31, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288... | en.prnasia... |
| 26.10.2023 | Bridge Biotherapeutics Announces Positive Recommendation fro... | The independent data monitoring committee (IDMC) recommended the continuation of the BBT-877 Phase 2... | en.prnasia... |
| 12.07.2023 | Bridge Biotherapeutics Joins PROLIFIC, the Prognostic Lung F... | Bridge to join as an industry member to advance the science of early detection and speed development... | en.prnasia... |
| 30.05.2023 | Bridge Biotherapeutics to Present at the 2023 BIO Internatio... | SEONGNAM, South Korea and CAMBRIDGE, Mass., May 30, 2023 /PRNewswire/ -- Bridge Biotherapeutics Inc.... | en.prnasia... |
| 24.04.2023 | Bridge Biotherapeutics Receives FDA Authorization to Proceed... | The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed The latest pr... | en.prnasia... |
| 19.04.2023 | Bridge Biotherapeutics Releases Updated Preclinical Data for... | New preclinical data validate anti-tumor efficacy and intracranial activity of the drug candidate Br... | en.prnasia... |
| 13.04.2023 | Bridge Biotherapeutics Announces First Patient Dosed in its ... | SEONGNAM, South Korea and CAMBRIDGE, Mass., April 13, 2023 /PRNewswire/ -- Bridge Biotherapeutics (K... | en.prnasia... |
| 15.03.2023 | Bridge Biotherapeutics to Present Updated Preclinical Data o... | The abstract of BBT-207 preclinical studies is now available on the AACR website Preclinical data su... | en.prnasia... |
Show more